Bradycardia Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

  • Single User License $3500

Bradycardia Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

Status : January, 2021 | Medical Devices

Report Digest


Global Bradycardia Market: Snapshot

Bradycardia, which is a condition pertaining to slow heart rate, affects from the very young to the oldest, although geriatrics are mostly diagnosed for this heart-beat irregularity. It has been estimated that nearly 600,000 people across the world receive treatment for bradycardia, commonly caused by a problem with the S-A node or an issue in the electrical pathways of the heart.

The global bradycardia market involves the diagnosis of the condition and the treatment. For diagnostics, electrocardiogram (ECG) tests are performed, which are readily opted by the patients as they are painless. For the treatment of bradycardia, pacemakers are most commonly used, which can be customized according to the need of the patient. Depending on individual condition, a pacemaker may replace S-A node signals, help in maintaining the normal timing sequence, and enable lower chambers of the heart to contract at a required rate. With technological advancements, latest ECG tests and pacemakers are quite accurate and dependable, and hence the demand in the bradycardia market is expected to expand at a healthy CAGR during the forecast period of 2017 to 2025.

This report on the global bradycardia market provides quantitative and qualitative evaluations of the market in its current scenario and estimates the future state, based on in-depth assessment of all the factors that may impact the inflow of the demand in the near future. The report also profiles a number of key companies in order to represent the competitive landscape.

Global Bradycardia Market: Overview

Bradycardia, also known as, bradyarrhythmia is one of the most important cardiac diseases. Bradycardia is a medically abnormal state of heart in which the pulse rate (heart beats) is less than 60 beats per minute (BPM). Bradycardia, in simplest sense, is a condition, in which heart shows decline in its efficiency. If heart shows around 50 BPM, it brings symptoms like tiredness, weakness, fatigue, dizziness and skin fainting. This is considered as symptom of heart diseases. Further, if the heart rate is less than 40 BPM, it must be taken seriously to treat. 

Bradycardia is caused due to various cardiac and non-cardiac symptoms. Non-cardiac symptoms mainly include abusive drugs consumption, endocrine and metabolic dysfunctioning, neurologic factors and electrolyte imbalance. Further, prolonged sleep and autoimmune response are the other major causes. Whereas, cardiac caused include valvular and vascular heart diseases, ischemic heart disease and cardiac arrhythmia. Bradycardia is usually diagnosed by pulse rate monitors and ECG. 

Global Bradycardia Market: Summary

The global bradycardia market is segmented on the basis of two parameters: the types of disease and therapeutic treatments. On the basis of types of disease, it is divided into ventricular, atrioventricular nodal, atrial, and infantile bradycardia. On the basis of drugs and therapy, the market is segmented into epinephrine, dopamine, adrenaline, levsin, and atropine. Hypothyroidism treatment is also useful in bradycardia, which includes liotix, liothyronine, and levothyroxine. Although drug therapies are largely available, the usual and core therapeutic aspect is pacemaker installation. Pacemakers are considered as the prime therapy for bradycardia and arrhythmia. Drugs and pacemaker therapies are used specifically when the heart slows down to lower than 50 BPM. 

The global bradycardia market is segmented on the basis of geography, into North America, Europe, Asia-Pacific and the rest of the world. The North American region has so far been the dominant one in the global bradycardia market, owing to a fast rate of growth in its number of bradycardia patients. On the other hand, Asia-Pacific and RoW regions are showing a lot of promise for growth over the coming years, owing to a rise in awareness of diagnostics and monitoring in cardiac diseases and the growth of medical infrastructure. 

Global Bradycardia Market: Trends and Prospects

The global bradycardia market is expected to grow are a very fast pace during between 2017 and 2025, likely to be driven by factors such as the increasing prevalence of cardiac diseases and bradycardia, extensive R&D efforts, and a rise in awareness of cardiac disease monitoring. Other factors such as the evolution of medical and healthcare infrastructure and growth in medical expenditure in emerging economies are also promoting the global bradycardia market’s growth. 

According to a report published by the U.S. Centers for Disease Control and Prevention (CDC) in 2008, the prevalence of bradycardia was in close to 15% of males and 7% of females from the total U.S. population. Extensive R&D practices are consequently being conducted, further benefittin the global bradycardia market. Considering the growth opportunities in the market, pharmaceutical companies and medical devices manufacturers have taken a serious part in the bradycardia R&D practices. However, key restraints to the global bradycardia market include lack of awareness and tendency of ignorance towards the symptoms, especially in emerging economies from APAC, The MEA, and Latin America, and the generally high cost of pacemaker-based treatments. 

Key players operating in the global bradycardia market include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Mayo Clinic, and UMC Utrecht Holding BV.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?